首页> 美国政府科技报告 >Pilot Clinical Trial to Assess Percutaneous Segmental Mastectomy in Women with Malignant Tumors < or = 1.0 Centimeter
【24h】

Pilot Clinical Trial to Assess Percutaneous Segmental Mastectomy in Women with Malignant Tumors < or = 1.0 Centimeter

机译:评估恶性肿瘤患者经皮节段性乳房切除术的临床试验<或= 1.0厘米

获取原文

摘要

The operative treatment of primary breast cancer has changed. The radical mastectomy has been replaced by the modified radical mastectomy. Increasingly breast-conserving operations are being accepted as the standard of care. The logical culmination of the retreat from radical mastectomy is tumor extirpation without open surgical procedures. The biological rationale for this is the same rationale that resulted in the abandonment of en bloc tumor resection in favor of breast preservation. Recent& technology permits highly accurate tissue sampling of non-palpable mammographically imaged densities. An unanticipated observation associated with the use of stereotactic core biopsy was the complete removal of tumors up to 1.2 centimeters in diameter.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号